Diagnostic Approach for Suspected Pleural Tuberculosis

Diagnostic Strategy

The British Thoracic Society recommends tissue sampling via pleural biopsy as the preferred diagnostic approach for suspected tuberculous pleural effusion, combined with pleural fluid adenosine deaminase (ADA) testing in appropriate populations 1
For suspected tuberculous pleurisy, perform thoracentesis and send pleural fluid for microbiological studies, including acid-fast bacilli smear and TB culture, with a yield maximized by using both sterile containers and blood culture bottles 1, 2
Cell counts and chemistries are essential for characterizing the effusion as lymphocyte-predominant exudate, with ADA levels being a critical biomarker with 91% sensitivity and 88% specificity in high TB prevalence populations 3, 4, 5
Interferon-gamma (IFN-γ) levels can be measured with 89% sensitivity and 97% specificity for pleural TB, providing an additional diagnostic tool 3, 6

ADA testing is valuable in high prevalence populations for diagnosing tuberculous pleural effusion, but its utility depends on local TB prevalence, with a normal ADA making TB very unlikely in low prevalence areas 1, 3, 5
ADA may be falsely elevated in empyema, parapneumonic effusions, and rheumatoid pleurisy, reducing specificity, and ADA levels may not be elevated in HIV-positive patients with TB, creating false negatives 5

Histological examination of pleural tissue has 69-97% sensitivity for diagnosing tuberculous pleural effusion, far superior to fluid culture, with the British Thoracic Society strongly recommending pleural biopsy for all suspected cases 1, 7
Image-guided or thoracoscopic biopsy should be used, with tissue sent for both histology and mycobacterial culture with drug susceptibility testing, as histological findings of granulomas are highly suggestive even when cultures remain negative 1, 7, 8

The standard first-line anti-tuberculosis treatment for tuberculous pleurisy is 2 months of isoniazid, rifampin, pyrazinamide, and ethambutol (2HRZE), followed by 4 months of isoniazid and rifampin (4HR), as recommended by the British Thoracic Society 1